These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 2702102

  • 21. [Risk factors affecting the long-term outcome of IgA nephropathy].
    Yang NS, Wu QQ, Du Y, Zhang R, Li YJ, Ye RG, Yu XQ.
    Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):597-600. PubMed ID: 16194415
    [Abstract] [Full Text] [Related]

  • 22. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [Abstract] [Full Text] [Related]

  • 23. Histological differences in new-onset IgA nephropathy between children and adults.
    Ikezumi Y, Suzuki T, Imai N, Ueno M, Narita I, Kawachi H, Shimizu F, Nikolic-Paterson DJ, Uchiyama M.
    Nephrol Dial Transplant; 2006 Dec; 21(12):3466-74. PubMed ID: 16935895
    [Abstract] [Full Text] [Related]

  • 24. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM.
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [Abstract] [Full Text] [Related]

  • 25. IgA nephropathy patients with partial crescent formation benefit from immunosuppressants: evidence from repeat renal biopsy.
    Luo MN, Pan Q, Huang ZQ, Li SM, Xu YZ, Liu HF.
    Discov Med; 2020 Oct; 30(159):19-25. PubMed ID: 33357359
    [Abstract] [Full Text] [Related]

  • 26. [Influence of intensity, localization and type of deposits in renal biopsy for disease symptoms and follow up in children with IgA nephropathy].
    Cichoń-Kawa K, Mizerska-Wasiak M, Małdyk J, Turczyn A, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Bieniaś B, Sikora P, Gadomska-Prokop K, Grenda R, Pańczyk-Tomaszewska M.
    Pol Merkur Lekarski; 2018 Apr 23; 44(262):177-182. PubMed ID: 29775444
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Effects of methylprednisolone pulse therapy on progressive IgA nephropathy].
    Yoshimura M, Kida H, Saito Y, Takaeda M, Sugioka G.
    Nihon Jinzo Gakkai Shi; 1991 Aug 23; 33(8):761-8. PubMed ID: 1770636
    [Abstract] [Full Text] [Related]

  • 29. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases.
    Haas M.
    Am J Kidney Dis; 1997 Jun 23; 29(6):829-42. PubMed ID: 9186068
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Treatment of IgA nephropathy in children: efficacy of alternate-day oral prednisone.
    Waldo FB, Wyatt RJ, Kelly DR, Herrera GA, Benfield MR, Kohaut EC.
    Pediatr Nephrol; 1993 Oct 23; 7(5):529-32. PubMed ID: 8251315
    [Abstract] [Full Text] [Related]

  • 32. An important role of glomerular segmental lesions on progression of IgA nephropathy: a multivariate analysis.
    Katafuchi R, Oh Y, Hori K, Komota T, Yanase T, Ikeda K, Omura T, Fujimi S.
    Clin Nephrol; 1994 Apr 23; 41(4):191-8. PubMed ID: 8026110
    [Abstract] [Full Text] [Related]

  • 33. C3 deposition in serially biopsied children with IgA nephropathy.
    Hara M, Yoshida R, Inaba S, Higuchi A, Suzuki Y, Okada T, Tanizawa T.
    Acta Paediatr Jpn; 1991 Jun 23; 33(3):345-51. PubMed ID: 1785330
    [Abstract] [Full Text] [Related]

  • 34. Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy.
    Kamei K, Nakanishi K, Ito S, Ishikura K, Hataya H, Honda M, Nozu K, Iijima K, Shima Y, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Group.
    Pediatr Nephrol; 2015 Jun 23; 30(6):961-7. PubMed ID: 25487669
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Tonsillectomy with methylprednisolone pulse therapy as rescue treatment for steroid-resistant IgA nephropathy in children.
    Kawasaki Y, Suyama K, Abe Y, Ushijima Y, Sakai N, Takano K, Ito M, Hashimoto K, Hosoya M.
    Tohoku J Exp Med; 2009 May 23; 218(1):11-6. PubMed ID: 19398868
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž, Laurinavičius A, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    Medicina (Kaunas); 2016 May 23; 52(6):340-348. PubMed ID: 27932191
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.